XSHG
605589
, Last price
Name
Jinan Shengquan Group Share Holding Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Jinan Shengquan Group Share Holding Co., Ltd. is a diverse enterprise primarily focused on the research, development, manufacturing, and commercialization of various chemical and advanced materials. The company's product portfolio includes an extensive range of phenolic resins, which are utilized across numerous applications such as tire rubber, electronics, coated sand, composite production, friction materials, refractories, and abrasives. Additionally, it produces epoxy resins. In the foundry sector, Jinan Shengquan offers a comprehensive selection of materials. These encompass furan, alkaline phenolic, and cold box resins, along with crucial components like riser sleeves, coatings, filters, metallurgical substances, and auxiliary agents. Its foundry offerings are further complemented by porous cellulose and specialized SQ boards. Expanding beyond its core industrial chemicals, the company has a significant presence in the health industry, providing products such as heal fiber, VTS new materials, L-arabinose, D-xylose, and mother liquor. This segment also includes essential medical supplies like respirators, disposable face masks, and medical face masks. Furthermore, Jinan Shengquan is a contributor to the new energy sector, supplying advanced products like lithium titanate batteries, super capacitors, solar street lamps, and related modules. Its material science expertise also extends to biomass materials. Founded in 1979, the company is headquartered in Zhangqiu, China.
Headquarters & legal address
山东省济南市章丘区刁镇工业经济开发区
济南市, SD 100000
CN
济南市, SD 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2019‑00 | 2018‑12 | 2017‑12 | 2017‑00 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||